BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vij M, Veerankutty FH, Rammohan A, Rela M. Combined hepatocellular cholangiocarcinoma: A clinicopathological update. World J Hepatol 2024; 16(5): 766-775 [PMID: 38818284 DOI: 10.4254/wjh.v16.i5.766]
URL: https://www.wjgnet.com/1948-5182/full/v16/i5/766.htm
Number Citing Articles
1
Talha Waqas, Mounir Lahlouh, Sébastien Mulé, Yasmina Chenoune. AI-Driven Multimodal Approach: A Comprehensive Framework for Liver Tumor Diagnosis and Prognosis Using MRI2025 6th International Conference on Bio-engineering for Smart Technologies (BioSMART) 2025; : 1 doi: 10.1109/BioSMART66413.2025.11046047
2
Guo-qian He, Qing Li, Xiao-yu Jing, Jian Li, Ju Gao, Xia Guo. Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusionMolecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02190-w
3
Jung Yong Hong, Dong Hyun Sinn, Sang Yun Ha. Systemic therapy for combined hepatocellular-cholangiocarcinoma: a comprehensive review of chemotherapy, immunotherapy, and targeted therapyJournal of Liver Cancer 2026; 26(1): 36 doi: 10.17998/jlc.2026.03.02
4
E. I. Zakurdaev, N. P. Chizhikov, Z. A. Bagatelia, P. A. A. Drozdov. Case report of rare aggressive hepatocholangiocarcinoma with early distant metastasesOncopathology 2026; 8(4): 63 doi: 10.17650/2618-7019-2025-8-4-63-66
5
Yue Li, Du He, Zi-Jian Lu, Xia-Fei Gu, Xiao-Yu Liu, Min Chen, Yin-Xia Tu, Yu Zhou, Gemma Owen, Xian Zhang, Dan Jiang. Clinicopathological characteristics and prognosis of combined hepatocellular cholangiocarcinomaBMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12970-8
6
Cemil Colak, Sami Akbulut. Edge learning applications in the prediction and classification of combined hepatocellular-cholangiocarcinoma: A comprehensive narrative reviewWorld Journal of Clinical Oncology 2025; 16(7): 107246 doi: 10.5306/wjco.v16.i7.107246
7
Lijie Ma, Qiang Xia, Meng Sha. Outcomes of Liver Transplantation in Incidental Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma: An Exceptional Perspective from a Single-Center ExperienceJournal of Clinical Medicine 2025; 14(24): 8857 doi: 10.3390/jcm14248857
8
Woohyung Lee, Kwang Pyo Hong, Jae Hoon Lee, Mirang Lee, Minkyu Sung, Seung Jae Lee, Ki Byung Song, Dae Wook Hwang, Song Cheol Kim. Surgical management of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a narrative review of principles, technical nuances, and emerging strategiesJournal of Liver Cancer 2026; 26(1): 19 doi: 10.17998/jlc.2026.01.24
9
Gilton Marques Fonseca, Paulo Herman. Reply to “Comment on ‘Prognostic Impact of the Cholangiolar Component in Combined Hepatocellular‐Cholangiocarcinoma: Insights From a Western Single‐Center Study’”Journal of Surgical Oncology 2025; 131(6): 988 doi: 10.1002/jso.28056
10
Shaodian Xu, Julien Calderaro. Combined Hepatocellular-Cholangiocarcinoma: A Clinical and Molecular ReviewSeminars in Liver Disease 2025; 45(04): 476 doi: 10.1055/a-2730-9074
11
Oriana Lo Re, Christian Corti, Lucia Cerrito, Eleonora Cesari, Elisabetta Creta, Flavio De Maio, Alessia Di Prima, Vincenzo Facciuto, Clelia Ferraro, Eleonora Huqi, Rosa Liotta, Margot Lo Pinto, Duilio Pagano, Riccardo Perriera, Valentina Petito, Giulia Santarelli, Francesco Santopaolo, Leonardo Stella, Floriana Tortomasi, Claudio Sette, Salvatore Gruttadauria, Felice Giuliante, Giovanni Zito, Francesca Romana Ponziani. Establishment of Patient-Derived Organoids from Hepatocellular Carcinoma: Preliminary Data on Yield, Histopathological Concordance, and Methodological ChallengesCells 2026; 15(2): 125 doi: 10.3390/cells15020125